drugset / Trial / NCT01996839
Loteprednol Ophthalmic Gel for the Treatment of Ocular Inflammation and Pain Following Cataract Surgery
RandomizedParallel-groupDouble-blindTreatment
Summary
The objective of this study is to evaluate the safety and efficacy of loteprednol etabonate ophthalmic gel
Timeline
- Start
- 2013-12
- Primary completion
- 2014-05
- Completion
- 2014-07
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | Loteprednol Etabonate | Other / unclassified | — | Topical |